Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Abcely Logo
Abcely Growth Score
87
CB Rank
103119
Heat Score
48
Abcely is a biotech firm that is working on a novel anti-cancer medication.
Founded
obfuscation
PrivateSeed Nantes, Pays de la Loire, France1-10 www.abcely.com
Biotechnology
Health Care
Overview

Abcely
Total Funding
obfuscation
Growth Score
87
Heat Score
48

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score87
-4 pts
in past quarter
Heat Score 48
-18 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Abcely

CB Rank
103119
Abcely is a biotech firm that is working on a novel anti-cancer medication.
Founded
obfuscation
PrivateSeed Nantes, Pays de la Loire, France1-10 www.abcely.com
Biotechnology
Health Care

Funding Rounds

Seed
OBF
in
obfuscation

Details

Operating Status Active
Company Type For Profit
About the Company
Abcely is a biotech firm that is working on a novel anti-cancer medication.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ABC-101
An orally-active secretory IgA monoclonal antibody targeting carcinoembryonic antigen (CEA) for treating mucosal cancers.
ABC-201
An IgA monoclonal antibody under development for the treatment of endometriosis.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Abcely Logo
Seed Round - Abcely
3
obfuscation
GO CAPITALSeed
obfuscation
Seed Round - Abcely Logo
Seed Round - Abcely
3
obfuscation
GO CAPITALSeed
obfuscation
Seed Round - Abcely Logo
Seed Round - Abcely
3
obfuscation
GO CAPITALSeed
obfuscation
Seed Round - Abcely Logo
Seed Round - Abcely
3
obfuscation
GO CAPITALSeed
obfuscation
Seed Round - Abcely Logo
Seed Round - Abcely
3
obfuscation
GO CAPITALSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Abcely Logo
Seed Round - Abcely
3
obfuscation
GO CAPITALSeed
obfuscation
Seed Round - Abcely Logo
Seed Round - Abcely
3
obfuscation
GO CAPITALSeed
obfuscation
Seed Round - Abcely Logo
Seed Round - Abcely
3
obfuscation
GO CAPITALSeed
obfuscation
Seed Round - Abcely Logo
Seed Round - Abcely
3
obfuscation
GO CAPITALSeed
obfuscation
Seed Round - Abcely Logo
Seed Round - Abcely
3
obfuscation
GO CAPITALSeed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
GO CAPITAL Logo
GO CAPITAL
Yes
Seed Round - Abcely Logo
Seed Round - Abcely
Leila Nicolas
GO CAPITAL Logo
GO CAPITAL
Yes
Seed Round - Abcely Logo
Seed Round - Abcely
Leila Nicolas
GO CAPITAL Logo
GO CAPITAL
Yes
Seed Round - Abcely Logo
Seed Round - Abcely
Leila Nicolas
GO CAPITAL Logo
GO CAPITAL
Yes
Seed Round - Abcely Logo
Seed Round - Abcely
Leila Nicolas
GO CAPITAL Logo
GO CAPITAL
Yes
Seed Round - Abcely Logo
Seed Round - Abcely
Leila Nicolas
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Board Members and Advisors 1 Contacts 1

Board Members and Advisors

News
Technology
View Tech Report

Monthly Web Visits

40

IT Spend

$155.5KThis year, Abcely is projected to spend $155.5K on IT, according to Aberdeen.

Active Website Tech Count

28Abcely is actively using 28 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

4Abcely has 1 registered patent in the 'Organic Chemistry' category, according to IPqwery. Additionally, Abcely has registered 3 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Abcely's headquarters? Abcely is located in Nantes, Pays de la Loire, France.Who invested in Abcely? Abcely has 3 investors including GO CAPITAL and  Angels Santé.When was the last funding round for Abcely? Abcely closed its last funding round on
obfuscation
from a Seed round.Who are Abcely's competitors? Alternatives and possible competitors to Abcely may include Pyxis Oncology, Genmab, and  Agenus.How much funding has Abcely raised to date? Abcely has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f8e1fc8 1)
|